Botanix Pharmaceuticals Limited (BXPHF)
BXPHF Stock Price Chart
Explore Botanix Pharmaceuticals Limited interactive price chart. Choose custom timeframes to analyze BXPHF price movements and trends.
BXPHF Company Profile
Discover essential business fundamentals and corporate details for Botanix Pharmaceuticals Limited (BXPHF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
9 Sept 2019
Employees
11.00
Website
https://www.botanixpharma.comCEO
Howie McKibbon
Description
Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIb clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase IIb clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. The company was incorporated in 1984 and is based in Leederville, Australia.
BXPHF Financial Timeline
Browse a chronological timeline of Botanix Pharmaceuticals Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 24 Feb 2026
Earnings released on 29 Aug 2025
EPS came in at -$0.02 matching the estimated -$0.02, while revenue for the quarter reached $3.56M , beating expectations by +3.94%.
Earnings released on 24 Apr 2025
EPS came in at -$0.01 falling short of the estimated $0.00 by -1.80K%, while revenue for the quarter reached $213.86K , missing expectations by -97.02%.
Earnings released on 30 Aug 2024
EPS came in at -$0.00 , while revenue for the quarter reached $1.13M .
Earnings released on 30 Apr 2024
EPS came in at -$0.00 , while revenue for the quarter reached $257.30K .
Earnings released on 30 Jun 2023
EPS came in at -$0.00 , while revenue for the quarter reached $349.96K .
Earnings released on 30 Dec 2022
EPS came in at -$0.00 , while revenue for the quarter reached $265.16K .
Earnings released on 30 Jun 2022
EPS came in at -$0.00 , while revenue for the quarter reached $947.07K .
Earnings released on 30 Dec 2021
EPS came in at -$0.00 .
Earnings released on 30 Jun 2021
EPS came in at -$0.00 , while revenue for the quarter reached -$70.57 .
Earnings released on 30 Dec 2020
EPS came in at $0.00 , while revenue for the quarter reached $2.64M .
BXPHF Stock Performance
Access detailed BXPHF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.